---
title: Lacrifresh HydraPF
---

[![Avizor](https://avizor.us/hubfs/raw_assets/public/themes/avizor/assets/images/logo-avizor-white.png)](https://avizor.us/?hsLang=es-us)

- Our Brands 
    - [Lacrifresh HydraMaxPF](https://avizor.us/lacrifresh-hydramax)
    - [Lacrifresh HydraPF](https://avizor.us/lacrifresh-hydra)
- [Private Label Solutions](https://avizor.us/private-labels)
- [About Avizor](https://avizor.us/about-us)
- [![](https://avizor.us/hubfs/raw_assets/public/themes/avizor/assets/images/eeuu-flag-color.svg) Talk to sales](https://avizor.us/talk-to-sales)

![Hero Lacrifresh HydraPF](https://avizor.us/hs-fs/hubfs/Hero%20Lacrifresh%20HydraPF.png?width=2880&height=1480&name=Hero%20Lacrifresh%20HydraPF.png "Hero Lacrifresh HydraPF")

# Lacrifresh HydraPF

Lacrifresh HydraPF is an ophthalmic lubricant designed to temporarily relieve burning, irritation, and discomfort due to dryness of the eye. Used as directed, it helps protect against further irritation and helps maintain ocular surface hydration to keep your eyes feeling comfortable. 

 

![carrusel1](https://avizor.us/hs-fs/hubfs/carrusel1.png?width=1064&height=1000&name=carrusel1.png "carrusel1")

![carrusel2](https://avizor.us/hs-fs/hubfs/carrusel2.png?width=1064&height=1000&name=carrusel2.png "carrusel2")

# Experience comfort and hydration with our eye drops

Lacrifresh HydraPF delivers soothing relief and helps maintain ocular hydration for dry, irritated eyes. Its preservative-free, pH-balanced formula is suitable for frequent use, helping to hydrate and ease discomfort caused by wind, sun, air conditioning, or prolonged screen exposure. 

![It is indicated for patients](https://avizor.us/hubfs/It%20is%20indicated%20for%20patients.svg "It is indicated for patients")

 Preservative-free

![Frequent use](https://avizor.us/hubfs/Solutions%20for%20sensitive%20eyes.svg "Frequent use")

 Suitable for Frequent Use

![Aqueous, buffered-1](https://avizor.us/hubfs/Aqueous%2c%20buffered-1.svg "Aqueous, buffered-1")

 pH-balanced formula

![Moisture rich formula](https://avizor.us/hubfs/Moisture%20rich%20formula.svg "Moisture rich formula")

 Suitable for use with all contact lenses

![5](https://avizor.us/hubfs/5.svg "5")

 Convenient multi-dose bottle

[Talk to sales](https://avizor.us/talk-to-sales)

## HydraPF

![benefits 1](https://avizor.us/hubfs/benefits%201.svg)

### Active Ingredients

Active Ingredients: glycerin, povidone. Inactive Ingredients: electrolytes, others (see full label). These components work together to lubricate the eye, help relieve dryness-related discomfort, and help maintain ocular comfort.

![benefits2](https://avizor.us/hubfs/benefits2.svg)

### Key Benefits

Helps reduce eye irritation when used as directed. Additionally, the product offers easy application and remains sterile for three months after opening, enhancing its practicality.

![benefits3](https://avizor.us/hubfs/benefits3.svg)

### Usage Details

With a hypotonic formulation featuring an osmolality of approximately 220 mOsm/kg and a viscosity of approximately 22 cP, it is offered in a convenient 0.33 fl oz (10 mL) format. Suitable for use with contact lenses when used as directed.

##### Avizor manufactures in compliance with applicable quality and regulatory requirements

![FDA logo](https://avizor.us/hs-fs/hubfs/FDA-1.png?width=240&height=240&name=FDA-1.png "FDA logo")

![UL_Avizor](https://avizor.us/hs-fs/hubfs/UL_Avizor.webp?width=240&height=240&name=UL_Avizor.webp "UL_Avizor")

![CGMP logo](https://avizor.us/hs-fs/hubfs/CGMP-3.png?width=1280&height=1280&name=CGMP-3.png "CGMP logo")

![USP-3](https://avizor.us/hs-fs/hubfs/USP-3.png?width=1281&height=1280&name=USP-3.png "USP-3")

![ISO13485 v2](https://avizor.us/hs-fs/hubfs/ISO13485%20v2.webp?width=240&height=240&name=ISO13485%20v2.webp "ISO13485 v2")

![CE logo](https://avizor.us/hs-fs/hubfs/CE-1.png?width=240&height=240&name=CE-1.png "CE logo")

## Frequently asked questions

Have more questions? Contact sales to get the answer you're looking for:

What is this product used for? 

This product is an ophthalmic lubricant that **temporarily relieves** burning, irritation, and discomfort due to dryness of the eye. It is not intended to treat underlying eye diseases.

Can it be used with contact lenses?

It may be used with contact lenses as directed, but always follow the product instructions and consult your eye care professional.

 

How often can I apply it?

Instill one or two drops as needed. Do not exceed the directions on the package or those given by your eye care professional.

Is this product FDA approved?

This product is marketed under applicable U.S. regulations.

 Can I use it if I have sensitive eyes?

The formulation is designed for ocular tolerance; however, if you experience persistent irritation or an adverse reaction, discontinue use and consult an eye care professional.

 How long does each application last?

Duration of relief may vary between users. This formulation is intended to provide temporary relief as directed.

Where can I buy AVIZOR products in the United States?

AVIZOR products are distributed through a growing network of opticians, pharmacies, drugstores, major retail and grocery chains, as well as selected online retailers.  
Currently, AVIZOR products are not available through hospitals or clinics in the United States.

## Interested in selling our global brands or a private brand partnership?

[Talk to sales](https://avizor.us)

![gota](https://avizor.us/hubfs/gota.svg "gota")

![Avizor](https://avizor.us/hubfs/raw_assets/public/themes/avizor/assets/images/logo_avizor.svg)

##### Menu

- [Home](https://avizor.us)
- [Lacrifresh HydraMaxPF](https://avizor.us/lacrifresh-hydramax)
- [Lacrifresh HydraPF](https://avizor.us/lacrifresh-hydra)
- [About Avizor](https://avizor.us/about-us)

##### Support

- [Talk to sales](https://avizor.us/talk-to-sales)
- [Privacy notice](https://avizor.us/privacy-notice)
- [Cookie policy](https://avizor.us/cookie-policy)

- <https://www.instagram.com/avizor_international/>
- <https://es.linkedin.com/>

---

Avizor USA, Corp. 2026. All rights reserved.

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/Hero%20Lacrifresh%20HydraPF.png",
  "description" : "Hero Lacrifresh HydraPF",
  "name" : "Hero Lacrifresh HydraPF"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/carrusel1.png",
  "description" : "carrusel1",
  "name" : "carrusel1"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/carrusel2.png",
  "description" : "carrusel2",
  "name" : "carrusel2"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/It%20is%20indicated%20for%20patients.svg",
  "description" : "It is indicated for patients",
  "name" : "It is indicated for patients"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/Solutions%20for%20sensitive%20eyes.svg",
  "description" : "Frequent use",
  "name" : "Frequent use"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/Aqueous%2c%20buffered-1.svg",
  "description" : "Aqueous, buffered-1",
  "name" : "Aqueous, buffered-1"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/Moisture%20rich%20formula.svg",
  "description" : "Moisture rich formula",
  "name" : "Moisture rich formula"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/5.svg",
  "description" : "5",
  "name" : "5"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/FDA-1.png",
  "description" : "FDA logo",
  "name" : "FDA logo"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/UL_Avizor.webp",
  "description" : "UL_Avizor",
  "name" : "UL_Avizor"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/CGMP-3.png",
  "description" : "CGMP logo",
  "name" : "CGMP logo"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/USP-3.png",
  "description" : "USP-3",
  "name" : "USP-3"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/ISO13485%20v2.webp",
  "description" : "ISO13485 v2",
  "name" : "ISO13485 v2"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/CE-1.png",
  "description" : "CE logo",
  "name" : "CE logo"
}
```

```json
{
  "@context" : "https://schema.org",
  "@type" : "ImageObject",
  "author" : "avizor",
  "contentUrl" : "https://146525099.fs1.hubspotusercontent-eu1.net/hubfs/146525099/gota.svg",
  "description" : "gota",
  "name" : "gota"
}
```